|
Volumn 21, Issue 5, 2001, Pages 3313-3321
|
Improved safety, pharmacokinetics and therapeutic efficacy profiles of a novel liposomal formulation of mitoxantrone
a a a a a a |
Author keywords
Experimental chemotherapy; Liposomal delivery; Mitoxantrone
|
Indexed keywords
LIPOSOME;
MITOXANTRONE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER SURVIVAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG SAFETY;
FEMALE;
HISTOPATHOLOGY;
HUMAN;
HUMAN CELL;
IC 50;
IN VITRO STUDY;
IN VIVO STUDY;
LEUKEMIA;
MALE;
MORTALITY;
MOUSE;
MOUSE STRAIN;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HL-60 CELLS;
HUMANS;
LEUKEMIA L1210;
LIPOSOMES;
MALE;
MICE;
MICE, INBRED BALB C;
MITOXANTRONE;
TISSUE DISTRIBUTION;
|
EID: 0035569857
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (41)
|
References (28)
|